Shape CopyShapeLEARN MORE Group 4Rectangle 5 CopyFacebookRectangle 7 Copy 3Consulting IconPage 1Products IconTraining IconGroup 4Group 3Shape Copy 3Shape CopyIRETA-Logo-02Left ArrowRight ArrowLocationMenuSearchFacebookGoogle PlusLinkedInTwitterYoutube
Addiction Research, Education and Training | IRETA
MenuClose
Menu
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
  • Overview
  • Blog
  • Contact
  • Home
  • MyIRETA
Addiction Research, Education and Training | IRETA
  • Home
  • Who We Are
  • Blog
  • Contact
  • myIRETA
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
Resources

What is the evidence for drug SBIRT in general health settings and what does it mean?

Posted on July 1, 2017 by IRETA

**Please note, we do not provide CEUs for viewing recorded webinars. If you are interested in receiving CEUs, you can view and register for our upcoming webinars here.**

Description

The best evidence for the efficacy of SBIRT is for hazardous alcohol use in primary care settings. This evidence has been used in support of SBIRT programs in many diverse settings, for patients with more severe conditions and for people who use other drugs. In this webinar, we will review the evidence on SBIRT for other drugs, hazardous use of drugs and drug disorders in general health settings. The bulk of the evidence suggests lack of efficacy.

Does this mean that drug use should not be identified in general health settings? If drug use is identified what should be done?

The National SBIRT ATTC would like to clarify the following information:

NORC’s Hospital BIG Initiative was initiated with support from a grant from the Hanley Family Foundation for the purpose of helping hospitals prepare to screen for risky alcohol and drug use of their patients, to provide brief treatments and medications as appropriate to their condition, and follow up after discharge. The Hospital BIG Initiative was designed to assist hospitals to implement the Joint Commissions SUB-1 to -4 measures and the appropriate treatments. Our continued work with the BIG Initiative has been supported through the National SBIRT ATTC and not from Diageo. NORC received no funds for our hospital work from Diageo, an international alcohol beverage company.

NORC has received two unrestricted educational grants from Diageo. The first helped underwrite development of an alcohol screening and brief intervention (SBI) training program for Employee Assistance professionals on SBI. Diageo ‘s grant made up a small part of our support for the BIG Initiative. Initial funding for the BIG Initiative came from NHTSA and SAMHSA, and started three years before we received any funding from Diageo. A second Diageo grant provided seed funds for the development of an interactive online training program to assist military health professionals and behavioral health professionals to screen active duty patients for high risk alcohol use, and provide brief counseling or referral to specialty care as appropriate. From the initial military SBI platform supported by the Diageo grant, the Defense Center of Excellence for Psychological Health and Traumatic Brain Injury and Department of Army awarded NORC a contract to finalize the training program. It was launched three weeks ago.

For more information please visit: http://bigsbirteducation.webs.com/thebiginitiative.htm

Presenter

Dr. Richard Saitz is a general internist and primary care physician, Chair and Professor of Community Health Sciences at Boston University (BU) School of Public Health, and Professor of Medicine at BU School of Medicine. He is a Fellow of the American College of Physicians and of the American Society of Addiction Medicine, and is certified by the American Boards of Internal Medicine and Addiction Medicine.

“Rich has no problem calling it straight. And sometimes that bothers people. But he has engendered a lot of respect in the field because he is true to the data.”
– Dr. Jeffrey Samet, professor of internal medicine, on Dr. Richard Saitz

Additional Resources

PowerPoint
Q&A

  • Type

  • Topics

  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
    • Training Resources
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Glossary
    • Useful & Credible Sources

611 William Penn Place, Suite 403 Pittsburgh, PA 15219 | P: 412-258-8565 | F: 412-391-2528
Terms & Conditions | Privacy Policy
© 2021 IRETA | Website by Imagebox.

Subscribe